Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
19.22
+0.22 (1.16%)
Feb 21, 2025, 4:00 PM EST - Market closed
Palvella Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | 7.06 | 18.69 | -27.55 |
| Stock-Based Compensation | 0.71 | 0.6 | 0.43 |
| Other Operating Activities | -17.79 | -29.85 | 10.66 |
| Change in Accounts Payable | 1.13 | -2.25 | 1.98 |
| Change in Other Net Operating Assets | 1.01 | -0.9 | -0.36 |
| Operating Cash Flow | -7.87 | -13.7 | -14.84 |
| Long-Term Debt Issued | - | 5 | - |
| Net Debt Issued (Repaid) | 17.43 | 5 | - |
| Issuance of Common Stock | - | - | 0.03 |
| Financing Cash Flow | 17.3 | 5 | 9.57 |
| Net Cash Flow | 9.43 | -8.7 | -5.27 |
| Free Cash Flow | -7.87 | -13.7 | -14.84 |
| Free Cash Flow Per Share | -1.38 | -2.36 | -2.59 |
| Levered Free Cash Flow | - | -9.96 | - |
| Unlevered Free Cash Flow | - | -9.96 | - |
| Change in Net Working Capital | - | 3.15 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.